1. Home
  2. MIST vs KULR Comparison

MIST vs KULR Comparison

Compare MIST & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • KULR
  • Stock Information
  • Founded
  • MIST 2003
  • KULR 2013
  • Country
  • MIST Canada
  • KULR United States
  • Employees
  • MIST N/A
  • KULR N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • MIST Health Care
  • KULR Technology
  • Exchange
  • MIST Nasdaq
  • KULR Nasdaq
  • Market Cap
  • MIST 163.2M
  • KULR 163.0M
  • IPO Year
  • MIST N/A
  • KULR N/A
  • Fundamental
  • Price
  • MIST $2.61
  • KULR $2.85
  • Analyst Decision
  • MIST Strong Buy
  • KULR Strong Buy
  • Analyst Count
  • MIST 3
  • KULR 2
  • Target Price
  • MIST $6.33
  • KULR $40.00
  • AVG Volume (30 Days)
  • MIST 2.8M
  • KULR 1.7M
  • Earning Date
  • MIST 11-12-2025
  • KULR 11-18-2025
  • Dividend Yield
  • MIST N/A
  • KULR N/A
  • EPS Growth
  • MIST N/A
  • KULR N/A
  • EPS
  • MIST N/A
  • KULR N/A
  • Revenue
  • MIST N/A
  • KULR $16,677,036.00
  • Revenue This Year
  • MIST N/A
  • KULR $27.50
  • Revenue Next Year
  • MIST N/A
  • KULR $164.50
  • P/E Ratio
  • MIST N/A
  • KULR N/A
  • Revenue Growth
  • MIST N/A
  • KULR 71.92
  • 52 Week Low
  • MIST $0.63
  • KULR $2.15
  • 52 Week High
  • MIST $2.75
  • KULR $43.92
  • Technical
  • Relative Strength Index (RSI)
  • MIST 74.94
  • KULR 42.08
  • Support Level
  • MIST $2.31
  • KULR $2.15
  • Resistance Level
  • MIST $2.49
  • KULR $2.76
  • Average True Range (ATR)
  • MIST 0.19
  • KULR 0.22
  • MACD
  • MIST 0.06
  • KULR 0.03
  • Stochastic Oscillator
  • MIST 95.50
  • KULR 59.13

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.

Share on Social Networks: